News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Conference News THT 2025 Experts Hash Out Recommendations for Impella CP After DanGer Shock Todd Neale February 14, 2025
Presentation THT 2025 Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: Gregg Stone February 13, 2025
Presentation THT 2025 Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: David Cohen February 13, 2025
Presentation THT 2025 CINCH Registry: 5-Year Evidence of Efficacy and Durability Presenter: Klaus Witte February 12, 2025
Presentation THT 2025 Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence Presenter: Thitiphan Srikulmontri February 12, 2025
Presentation THT 2025 SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli Presenter: Howard Herrmann February 12, 2025
Presentation THT 2025 Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence Presenter: Marco Metra February 12, 2025
Presentation THT 2025 Resurgence of Interest in the Role of Inflammation in HF Presenter: Douglas Mann February 11, 2025
Presentation THT 2025 Obesity: Assessing the Weight of the Evidence Presenter: Milton Packer February 11, 2025
Presentation THT 2025 MRAs Redux: New Evidence in Heart Failure Presenter: Scott Solomon February 11, 2025
Presentation THT 2025 Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025? Presenter: Martin Maron February 11, 2025
Presentation THT 2025 Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF Presenter: Gad Cotter February 11, 2025
Presentation THT 2024 Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock Presenter: James W. Schurr March 06, 2024
Presentation THT 2024 AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial Presenter: Deya Alkhatib March 06, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
Presentation THT 2024 A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery Presenter: Elena M. Donald March 04, 2024
Presentation THT 2024 Copulsation: The Evidence That It Matters Presenter: Ulrich P. Jorde March 04, 2024
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023